The Biochemical Basis of Immunodeficiency Disease

Overview

Journal Eur J Pediatr

Specialty Pediatrics

Date 1980 Oct 1

PMID 6256171

Citations 2

Authors

K O Raivio

Affiliations

Soon will be listed here.

Citing Articles

Lymphocyte dysfunction in cartilage hair hypoplasia. II. Evidence for a cell cycle specific defect in T cell growth.

Pierce G, POLMAR S Clin Exp Immunol. 1982; 50(3):621-8.

PMID: 6984669 PMC: 1536810.

Severe combined immunodeficiency: treatment by bone marrow transplantation in 15 infants using HLA-haploidentical donors.

Friedrich W, Goldmann S, Ebell W, Gaedicke G, Raghavachar A, Peter H Eur J Pediatr. 1985; 144(2):125-30.

PMID: 3899661 DOI: 10.1007/BF00451897.

References

Simmonds H, Sahota A, Potter C, Cameron J . Purine metabolism and immunodeficiency: urinary purine excretion as a diagnostic screening test in adenosine deaminase and purine nucleoside phosphorylase deficiency. Clin Sci Mol Med. 1978; 54(5):579-84. DOI: 10.1042/cs0540579. View

Carson D, Seegmiller J . Effect of adenosine deaminase inhibition upon human lymphocyte blastogenesis. J Clin Invest. 1976; 57(2):274-82. PMC: 436651. DOI: 10.1172/JCI108278. View

Ackeret C, Lluss H, HITZIG W . Hereditary sever combined immunodeficiency and adenosine deaminase deficiency. Pediatr Res. 1976; 10(1):67-70. DOI: 10.1203/00006450-197601000-00013. View

Ammann A, Wara D, Allen T . Immunotherapy and immunopathologic studies in a patient with nucleoside phosphorylase deficiency. Clin Immunol Immunopathol. 1978; 10(3):262-9. DOI: 10.1016/0090-1229(78)90180-0. View

Cohen A, Doyle D, Martin Jr D, Ammann A . Abnormal purine metabolism and purine overproduction in a patient deficient in purine nucleoside phosphorylase. N Engl J Med. 1976; 295(26):1449-54. DOI: 10.1056/NEJM197612232952603. View

Yu A, Kung F, BAKAY B, Nyhan W . In vitro and in vivo effect of deoxycoformycin in human T cell leukemia. Adv Exp Med Biol. 1979; 122B:373-9. DOI: 10.1007/978-1-4684-8559-2_60. View

Gudas L, Zannis V, Clift S, Ammann A, Staal G, Martin Jr D . Characterization of mutant subunits of human purine nucleoside phosphorylase. J Biol Chem. 1978; 253(24):8916-24. View

Thompson L, Boss G, Spiegelberg H, Jansen I, OConnor R, Waldmann T . Ecto-5'-nucleotidase activity in T and B lymphocytes from normal subjects and patients with congenital X-linked agammaglobulinemia. J Immunol. 1979; 123(6):2475-8. View

Mills G, Goldblum R, Newkirk K, Schmalstieg F . Urinary excretion of purines, purine nucleosides, and pseudouridine in adenosine deaminase deficiency. Biochem Med. 1978; 20(2):180-99. DOI: 10.1016/0006-2944(78)90065-0. View

10.

Creagan R, Tischfield J, NICHOLS E, Ruddle F . Letter: Autosomal assignment of the gene for the form of adenosine deaminase which is deficient in patients with combined immunodeficiency syndrome. Lancet. 1973; 2(7843):1449. DOI: 10.1016/s0140-6736(73)92850-x. View

11.

Johnson S, North M, Asherson G, Allsop J, Watts R, Webster A . Lymphocyte purine 5'-nucleotidase edficiency in primary hypogammaglobulinaemia. Lancet. 1977; 1(8004):168-70. DOI: 10.1016/s0140-6736(77)91765-2. View

12.

Coleman M, DOnofrio J, HUTTON J, HAHN L, Daoud A, Lampkin B . Identification and quantitation of adenine deoxynucleotides in erythrocytes of a patient with adenosine deaminase deficiency and severe combined immunodeficiency. J Biol Chem. 1978; 253(5):1619-26. View

13.

Hirschhorn R, Beratis N, Rosen F, Parkman R, Stern R, Polmar S . Adenosine-deaminase deficiency in a child diagnosed prenatally. Lancet. 1975; 1(7898):73-5. DOI: 10.1016/s0140-6736(75)91075-2. View

14.

HITZIG W, Dohmann U, Pluss H, VISCHER D . Hereditary transcobalamin II deficiency: clinical findings in a new family. J Pediatr. 1974; 85(5):622-8. DOI: 10.1016/s0022-3476(74)80503-2. View

15.

Cederbaum S, Kaitila I, Rimoin D, Stiehm E . The chondro-osseous dysplasia of adenosine deaminase deficiency with severe combined immunodeficiency. J Pediatr. 1976; 89(5):737-42. DOI: 10.1016/s0022-3476(76)80793-7. View

16.

Webster A, North M, Allsop J, Asherson G, Watts R . Purine metabolism in lymphocytes from patients with primary hypogammaglobulinaemia. Clin Exp Immunol. 1978; 31(3):456-63. PMC: 1541241. View

17.

POLMAR S, Stern R, Schwartz A, Wetzler E, Chase P, Hirschhorn R . Enzyme replacement therapy for adenosine deaminase deficiency and severe combined immunodeficiency. N Engl J Med. 1976; 295(24):1337-43. DOI: 10.1056/NEJM197612092952402. View

18.

POLMAR S, Wetzler E, Stern R, Hirschhorn R . Restoration of in-vitro lymphocyte responses with exogenous adenosine deaminase in a patient with severe combined immunodeficiency. Lancet. 1975; 2(7938):743-6. DOI: 10.1016/s0140-6736(75)90726-6. View

19.

Carson D, Kaye J . Deoxyribonucleoside toxicity in adenosine deaminase and purine nucleoside phosphorylase deficiency: implications for the development of new immunosuppressive agents. Ciba Found Symp. 1978; (68):115-33. DOI: 10.1002/9780470720516.ch8. View

20.

Wortmann R, Mitchell B, Edwards N, Fox I . Biochemical basis for differential deoxyadenosine toxicity to T and B lymphoblasts: role for 5'-nucleotidase. Proc Natl Acad Sci U S A. 1979; 76(5):2434-7. PMC: 383616. DOI: 10.1073/pnas.76.5.2434. View